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Association of Computed Tomographic Leg Muscle Characteristics
With Lower Limb and Cardiovascular Events in Patients With
Peripheral Artery Disease
Dylan R. Morris, MBBS;* Tristan A. Skalina, BHlthSci;* Tejas P. Singh, MBBS, MPH; Joseph V. Moxon, PhD;
Jonathan Golledge, MChir, FRCS, FRACS
Background-—Poor lower extremity physical performance is an independent predictor of unfavorable outcome in patients with
peripheral artery disease (PAD); however, few studies have assessed muscle characteristics on imaging directly.
Method and Results-—A novel 3-dimensional semi-automated protocol was developed to estimate leg muscle volume and density
(mean attenuation) from computed tomography images. Patients with PAD who underwent a lower extremity computed
tomography scan at a tertiary vascular surgery center were included, and were followed up using hospital records and linked data
as part of a retrospective cohort study. The primary outcomes were lower limb events (major amputation or peripheral
revascularization) and cardiovascular events (myocardial infarction, stroke, or cardiovascular death). Two hundred and twenty-three
patients with PAD were included (median age 69.0 years; 73% men) and followed for a median of 4.9 [2.6–7.0] years. During this
time there were 99 index lower limb events and 97 cardiovascular events. Low leg muscle density was associated with increased
risk of lower limb (rate ratio 1.41 [1.11–1.80] per SD reduction) and cardiovascular events (rate ratio 1.60 [1.29–1.99] per SD
reduction). Low muscle density remained an independent predictor of cardiovascular (but not lower limb) events, after adjusting for
age, sex, traditional cardiovascular risk factors, and angiographic PAD severity (rate ratio 1.39 [1.09–1.77] per lower SD). In
contrast, leg muscle volume was not associated with outcomes after adjusting for risk factors and PAD severity.
Conclusions-—Low leg muscle density, but not volume, is a strong, independent predictor of major cardiovascular events among
people with PAD. Further research is needed to understand the mechanisms underlying these associations. ( J Am Heart Assoc.
2018;7:e009943. DOI: 10.1161/JAHA.118.009943.)
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P eripheral artery disease (PAD) is an important cause ofpremature death and disability, affecting over 200 mil-
lion people worldwide.1,2 Patients with PAD have increased
risk of leg amputation and cardiovascular events, such as
myocardial infarction, stroke, and cardiovascular death.3,4
Even with current effective medical therapy, the risk of
cardiovascular events is 3 times higher in patients with PAD
compared with age- and sex- matched controls.5,6 More
effective treatments are needed to reduce the high risk of
lower limb and cardiovascular events in this population.
People with PAD experience debilitating lower limb symp-
toms, including intermittent claudication, rest pain, arterial
ulcers and gangrene, which severely limit their physical
activity.7 Randomized clinical trials demonstrate that super-
vised exercise therapy and home-based exercise interventions
improve walking performance in patients with PAD.8–11
However, PAD exercise programs are not widely available in
most countries, possibly because of limited evidence on the
long-term effects of exercise programs on lower limb and
cardiovascular events.12 Several studies suggest that lower
limb strength is a strong predictor of clinical outcome in
patients with PAD, but there is limited evidence on the direct
associations of leg muscle characteristics and PAD out-
comes.13–15 Better understanding of the prognostic signifi-
cance of particular leg muscle characteristics might help
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guide the development of effective treatments, such as
particular exercise modes, to improve PAD outcomes.16 The
aim of this study was to assess the association of computed
tomography (CT)–measured leg muscle characteristics with
adverse lower limb and cardiovascular events in patients with
PAD.
Methods
Study Population
This was a retrospective study of individuals presenting to a
vascular surgery department at a single tertiary hospital in
Queensland, Australia, between May 2004 and September
2012. Inclusion criteria for the study were the following:
(1) lower extremity CT angiogram conducted as part of routine
clinical assessment; (2) evidence of PAD on the CT angiogram
defined as ≥50% stenosis in at least 1 lower limb artery; and
(3) at least 1 follow-up assessment as an inpatient or
outpatient. Patients were excluded if they had not received
CT, had undergone a major lower-limb amputation before CT,
or had an angiogram that was of poor quality or included
imaging artifact (for example, from prosthetic implants). The
study, including a waiver of consent, was approved by the
Townsville Hospital and Health Service Human Research
Ethics Committee (HREC/12/QTHS/75; SA/12/QTHS/131)
and James Cook University (H4947). Public Health Act
approval was obtained, including approval to obtain data
from the Queensland Health Admitted Patient Data Collection
and the Queensland death register (RD004829; RD005150).
The data that support the findings of this study are available
from the corresponding author upon reasonable request by
bona fide academic researchers.
Clinical characteristics collected included presenting
symptoms, age, sex, diabetes mellitus, hypertension, smoking
history, ischemic heart disease, stroke, and current medica-
tions. Definitions for each of these variables are included in
the Supplementary Methods (Data S1). Intermittent claudica-
tion was defined as exertional lower-extremity muscle pain
that caused the participant to stop walking and resolved with
rest. Critical limb ischemia was defined as rest pain, arterial
ulcers or gangrene, attributable to objectively confirmed
occlusive PAD in line with international guidelines.17 Patients
who did not have classical symptoms of PAD (intermittent
claudication, rest pain, tissue loss) were categorized into a
group termed atypical symptoms. This group also included
patients who had imaging evidence of PAD (stenosis ≥50% in
1 major lower limb artery) and underwent CT angiography for
assessment of peripheral aneurysms.
Ankle–Brachial Pressure Index Measurement
Ankle–brachial pressure index (ABI) was assessed by qualified
vascular sonographers in a subgroup of the total sample, using
previously validated methods.18 Measurements were per-
formed within 12 months of the date of the CT scan and before
any revascularization procedure (further details in the Supple-
mentary Methods).
CT Image Acquisition
Lower-limb CT scans were requested as part of the clinical
care of the patients when peripheral revascularization was
being considered, or as part of investigation of concurrent
abdominal aortic aneurysm or lower-limb arterial aneurysm in
patients with concurrent PAD. CT scans were performed using
a 64-slice multiscanner (Philips, North Ryde, New South
Wales, Australia) with 3-mm axial slice thickness under a set
acquisition protocol.19 Images were transferred to a dedicated
workstation with OsiriX 64-bit software (version 5.8.1,
Pixmeo, Geneva, Switzerland) for analysis.
Assessment of PAD Severity From CT Angiograms
PAD severity was assessed using the ANGIO Score as
previously reported.19 In brief, the ANGIO Score represents
a novel method to quantify PAD severity through analysis of
CT angiogram images. A higher ANGIO Score indicates more
severe PAD (see Supplementary Methods). Patients were also
classified according to whether or not they had an occlusion
of the aorta or iliac arteries (defined as occlusion of aorto-iliac
arteries), common femoral, superficial femoral, or popliteal
arteries (defined as occlusion of the femoro-popliteal arteries)
Clinical Perspective
What Is New?
• Poor lower extremity physical performance is an indepen-
dent predictor of cardiovascular events in patients with
peripheral artery disease; however, few studies have
assessed leg muscle imaging characteristics directly.
• In this study, a novel 3-dimensional semi-automated proto-
col was developed to measure leg muscle characteristics in
patients with peripheral artery disease.
• Low leg muscle density was a strong predictor of both
adverse lower limb and cardiovascular events.
What Are the Clinical Implications?
• Further research is needed to better understand the reasons
for the association between low leg muscle density and
cardiovascular events among patients with peripheral artery
disease, and to identify interventions that uniquely improve
leg muscle density.
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or anterior tibial, posterior tibial, or peroneal arteries (defined
as occlusion of the infragenicular arteries) in the study leg. For
the purposes of statistical analysis, the study leg was chosen
as the side with the highest severity of PAD as judged by the
unilateral ANGIO Score. If both lower limbs had the same
ANGIO Score values or ANGIO Score measurements were not
undertaken because of artifact, then the study side was
assigned to the right leg.
Leg Muscle Assessment From CT Images
A protocol was developed to measure leg muscle volume and
radiological density (mean attenuation). Muscles imaged
within axial CT slices between the tibial tuberosity and the
ankle joint were included. For each of these slices, regions of
interest (ROIs) were constructed around the outside of visible
muscle tissue on the axial view. The ROI was defined as the
area from the deep fascia superficially to (but not including)
the periosteum of the relevant bones. The appropriate
positioning of the ROI was checked, and if required adjusted,
by examining multiple axial slices from the CT images. All
tissue not included within the ROI was excluded. Finally,
muscle within the ROI was isolated by applying a previously
defined radiological threshold (window level, 50 Hounsfield
units [HU]; window width, 100 HU) within the attenuation
range for skeletal muscle.20,21 The inbuilt “Calculate Volume”
tool was applied to estimate the volume and average
radiological density of the muscle within the 3-dimensional
reconstruction (Figure 1). Leg muscle volumes were stan-
dardized to the total volume of leg tissue between the tibial
tuberosity and ankle joint to adjust for differences in body
size, and reported as percentage muscle volume. Leg muscle
density was reported in HU, which is a measure of radiological
density. Formal reproducibility assessment of the CT leg
muscle measurements was performed by researchers who
were blinded to each other’s measurements (see Supplemen-
tary Methods).22
Follow-Up and Outcomes
Patients were followed up through attendance at outpatient
clinics and as an inpatient as part of their normal medical care
as previously described.23–25 Charts and hospital electronic
records of patients were reviewed by a vascular specialist.
Data were also linked with hospital admission records
obtained from the Queensland Health Admitted Patient Data
Collection and the Queensland death register (Data S1).19,26
The primary outcomes of the study were the following:
(1) major lower limb events, defined as any major lower-limb
amputation (ie, above or below the knee), or a lower-limb
revascularization procedure, such as bypass or stenting; and
(2) major cardiovascular events, defined as myocardial
infarction, stroke, or cardiovascular death.
Statistical Analyses
Sample size estimates suggested that 200 patients would
be sufficient to detect important associations between
skeletal muscle characteristics and the primary outcomes
(see Supplementary Methods).27 Continuous data were
Figure 1. CT assessment of leg muscle characteristics. Example of the assessment of leg muscle
characteristics from CT imaging. CT indicates computed tomography.
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generally not normally distributed according to histograms
and skewness and kurtosis tests. Therefore, they were
presented as median and interquartile range, and were
compared using Mann–Whitney or Kruskal–Wallis tests as
appropriate. Categorical data were presented as absolute
numbers and percentages, and were compared using Pear-
son’s v2 test.
The associations between leg muscle characteristics and
ANGIO Score were assessed using the Kruskal–Wallis test by
categorizing ANGIO Score into tertiles. The association
between muscle characteristics and ABI was assessed using
Spearman’s rho for correlation, and Kruskal–Wallis test for
association with clinically relevant ABI groups (ABI <0.5, ABI
≥0.5 and <0.9, ABI ≥0.9 and <1.4).
Kaplan–Meier curves and multivariate Cox regression were
used to assess the associations of muscle characteristics with
the primary composite outcomes. Follow-up time was defined
as the time between the date of the initial CT scan and
occurrence of the first event, or last clinical review. Patients
who did not have a primary event were censored at the time of
death or at their last recorded follow-up (up until May 5, 2017,
after when data were cleaned and analyzed). Kaplan–Meier
curves were used to illustrate the risk of lower limb and
cardiovascular events across tertiles of leg muscle volume and
density. Multivariate Cox proportional hazard analysis was then
used to assess the association of muscle characteristics with
primary outcome events, adjusting for relevant confounding
variables. Muscle characteristics were grouped into tertiles
according to equal numbers of outcome events, and rate ratios
(RR) for these categories were plotted against the mean
baseline values of each group. This allowed assessment of both
strength and pattern of associations. When several groups
were being compared with each other, the variance of the log
risk in each group (including the reference group) was
calculated from the variances and covariances of the log RR
values. This yielded group-specific confidence intervals (CIs) for
each group (including the reference group) that described the
effect of chance on the log risk in that 1 group. It also yielded
comparisons across groups that were unaffected by the choice
of reference group.28,29 Analyses of continuous exposures
were conducted and standardized to a 1 SD difference in
muscle volume or density. Proportional hazards assumptions
were confirmed by the Schoenfeld residuals test, with no
violations identified. Additional sensitivity analyses assessed
the robustness of the associations with major lower limb
amputation outcomes, in a lower-risk subgroup without critical
limb ischemia, after excluding the first 6 months of follow-up
and limiting cardiovascular events to non-perioperative events
Table 1. Characteristics of Patients With PAD Included in This Study in Relation to CT-Measured Leg Muscle Density Tertiles
Characteristic
Leg Muscle Density Tertiles
P ValueTertile 1 (n=59) Tertile 2 (n=74) Tertile 3 (n=90)
Age, y* 71.6 [66.8–77.7] 67.3 [60.3–74.5] 64.7 [58.0–72.5] <0.001
Sex (% males) 49 (83) 55 (74) 59 (66) 0.060
Diabetes mellitus 26 (44) 25 (34) 31 (34) 0.398
Current smokers 21 (36) 36 (49) 39 (43) 0.318
Hypertension 28 (47) 24 (32) 40 (44) 0.606
IHD 33 (56) 40 (54) 42 (47) 0.473
Stroke 6 (11) 9 (12) 11 (12) 0.935
Medications
Aspirin 39 (67) 49 (66) 70 (78) 0.198
Other antiplatelet 10 (17) 8 (11) 13 (14) 0.563
Warfarin 12 (21) 13 (18) 6 (7) 0.031
Statin 36 (62) 54 (73) 58 (64) 0.354
ACEI or ARB 37 (64) 41 (55) 51 (57) 0.586
b-Blocker 24 (41) 21 (28) 26 (29) 0.203
CCB 9 (16) 22 (30) 31 (34) 0.040
Metformin 9 (16) 15 (20) 16 (18) 0.778
Insulin 6 (10) 12 (16) 5 (6) 0.083
Values are frequency and percentage unless otherwise specified. Tertiles of leg muscle density grouped according to equal numbers of major cardiovascular events. Medication history
missing for 1 patient; stroke history missing in 2 patients. ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; CT,
computed tomography; IHD, ischemic heart disease; PAD, peripheral artery disease.
*Reported as median and interquartile range.
DOI: 10.1161/JAHA.118.009943 Journal of the American Heart Association 4
Leg Muscle Characteristics in PAD Morris et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on January 24, 2019
(by excluding follow-up after lower-limb revascularization or
major amputation). Analyses were conducted using STATA
version 15.1 (StataCorp, College Station, TX), and graphics
were produced with the R statistical package, version 3.4.4
(www.r-project.org/). All statistical tests were 2-sided and a P
value of <0.05 was considered significant.
Results
Population Characteristics
Two hundred sixty patients with PAD were initially included;
however, 37 were later excluded because of inadequate views
(n=29), joint prosthesis (n=4), major amputation (n=3), or
fracture (n=1), making accurate assessment of the CT images
impossible. Ultimately 223 patients were included, of whom
124 (56%) presented with intermittent claudication, 48 (21%)
had tissue loss, 35 (16%) had atypical presentations, 11 (5%)
had rest pain, and 5 (2%) had acute limb ischemia. The median
age of the population was 69.0 [60.8–74.2] years, and 73% of
patients were male. Over 40% of patients were current
smokers. Regarding medical therapy, 76% of patients were
receiving antiplatelet therapy, 70% were taking blood pres-
sure–lowering therapy, and 67% were prescribed a statin.
Detailed baseline characteristics of the cohort are shown in
Table 1.
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Figure 2. Association between PAD presentation and CT leg muscle characteristics. Box plots are shown
illustrating lower limb muscle characteristics according to PAD presentation. The thick band illustrates the
median, the box shows the interquartile range, and the whiskers demonstrate the farthest data points that
are not outliers. Acute limb ischemia was not included because of insufficient numbers (n=5). CT indicates
computed tomography; HU, Hounsfield units; I.C., intermittent claudication; PAD, peripheral artery disease.
Table 2. Association of ANGIO Score Categories With Leg CT Muscle Characteristics
Leg CT Muscle Characteristic Tertile 1 (n=57) Tertile 2 (n=70) Tertile 3 (n=74) P Value*
Leg muscle volume, % 54.8 [48.7–61.5] 52.4 [45.9–58.8] 51.8 [45.3–58.3] 0.214
Leg muscle density (HU) 45.6 [41.9–50.7] 45.2 [39.8–49.4] 41.6 [35.7–46.3] 0.003
Values are median [interquartile range]. Analysis includes 201 patients who had both leg muscle measurements and ANGIO Score assessment on CT. Tertiles of leg muscle characteristics
are grouped according to equal numbers of major cardiovascular events. CT indicates computed tomography; HU, Hounsfield units.
*Kruskal–Wallis test.
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Reproducibility of the CT Muscle Measurements
Leg muscle volume and density measurements were highly
reproducible. The concordance correlation coefficients were
>99% for both intraobserver and interobserver measure-
ments, with mean differences of <1% and 0.1 HU for leg
muscle volume and density, respectively (Table S1). Intra-
and interobserver repeatability were consistent across the
range of muscle measurements assessed (Figures S1
through S3).
Association of Presenting Symptoms and PAD
Severity With CT Muscle Characteristics
Figure 2 shows muscle characteristics for common PAD
presentations. Patients with tissue loss had significantly lower
Table 3. Lower Limb Skeletal Muscle Characteristics in Relation to Location of Peripheral Artery Occlusions
Occlusion No Occlusion
P ValueN Median [IQR] N Median [IQR]
Leg muscle volume, %
Aorto-iliac arteries 56 54.5 [43.5–60.6] 145 52.1 [46.1–58.6] 0.391
Femoro-popliteal arteries 85 54.2 [49.0–59.4] 116 51.7 [44.0–59.2] 0.140
Infragenicular arteries 125 50.3 [44.1–57.5] 76 57.7 [50.6–61.7] <0.001
Leg muscle density (HU)
Aorto-iliac arteries 56 44.5 [41.3–50.4] 145 43.5 [37.7–48.7] 0.149
Femoro-popliteal arteries 85 44.4 [38.3–49.8] 116 43.4 [38.7–48.1] 0.279
Infragenicular arteries 125 42.3 [36.1–48.1] 76 46.1 [41.6–50.2] 0.002
Analysis of 201 patients who had both leg muscle measurements and ANGIO Score assessment on CT. Skeletal muscle characteristics were compared with arterial occlusions in the same
leg. CT indicates computed tomography; HU, Hounsfield units; IQR, interquartile range.
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Figure 3. Association between leg muscle density and lower limb events among people with PAD. Left
panel shows the risk of lower-limb events over time according to leg muscle density tertile. Right panel
shows the relative risk of lower-limb events by density tertile, adjusted for age and sex. The size of the box
and vertical lines represent the 95% confidence intervals calculated from the variance of the log risk. CI
indicates confidence interval; HU, Hounsfield units; PAD, peripheral artery disease; RR, rate ratio.
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leg muscle volume and density than those with intermittent
claudication (P<0.001 for both). People with atypical symptoms
had lower calf muscle volume (P=0.017), but similar muscle
density (P=0.115) to people with intermittent claudication.
Interestingly, those with rest pain had similar muscle charac-
teristics to patients with intermittent claudication. More severe
peripheral athero-occlusive disease, measured using the ANGIO
Score, was associated with significantly lower leg muscle
density, but not muscle volume (Table 2). Many patients (44%)
had arterial occlusions at multiple levels. Those with occlusions
of the infragenicular arteries had significantly lower leg muscle
volume (P<0.001) and density (P=0.002) than those without
occluded infragenicular arteries. Interestingly, there was no
association between aorto-iliac or femoropopliteal occlusions
and leg muscle volume or density (Table 3). ABI measurements
were performed in some of the patients (n=41) near the time of
CT imaging (median of 1 day [0–25 days]). ABI was not
associated with leg muscle characteristics (Tables S2 and S3).
CT Leg Muscle Characteristics and Risk of Lower
Limb Events
Patients were followed up for a median of 4.9 [2.6–7.0] years
after CT imaging. During this time 92 patients (41%) had at least
1 lower limb arterial revascularization procedure, including 70
endovascular interventions and 46 open operations (some
patients had multiple revascularizations). Seventeen patients
required a major lower limb amputation, of which 10 were
below-knee amputations and 7 were above-knee amputations.
Overall 99 (44%) patients had at least 1 lower limb event. There
was a strong association between leg muscle density and lower
limb events (Figure 3). Patients in the lowest tertile of muscle
density had a 3-fold higher risk of revascularization or major
amputation (RR 2.87; 95% CI, 1.89–4.34) than those in the
highest tertile. Each SD decrease in leg muscle density
(7.3 HU) was associated with a 40% higher risk of lower limb
events (RR 1.41; CI, 1.11–1.80). The association was lost after
adjustment for cardiovascular risk factors and ANGIO Score. In
contrast, there was no association between leg muscle volume
and lower limb events (Figure S4).
Leg Muscle Characteristics and Risk of
Cardiovascular Events
Ninety-seven patients (43%) had at least 1 cardiovascular event
during follow-up, comprising 33 myocardial infarctions, 24
strokes, and 40 cardiovascular deaths. Leg muscle density was
significantly associated with risk of cardiovascular events
(Figure 4). People in the lowest tertile of density had 3 times the
risk of cardiovascular events of those in the highest tertile (RR,
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Figure 4. Association between leg muscle density and cardiovascular events among people with PAD. Left
panel shows the risk of cardiovascular events over time according to leg muscle density tertile. Right panel
shows the relative risk of cardiovascular events by density tertile, adjusted for age and sex. The size of the
box and vertical lines represent the 95% confidence intervals calculated from the variance of the log risk. CI
indicates confidence interval; HU, Hounsfield units; PAD, peripheral artery disease; RR, rate ratio.
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3.03; CI, 2.09–4.39). Each SD reduction in leg muscle density
(7.3 HU) was associated with a 60% higher risk of cardiovas-
cular events (RR, 1.60; CI, 1.29–1.99), and remained a strong
predictor of cardiovascular events after adjusting for cardio-
vascular risk factors and angiographic PAD severity (Figure 5).
In contrast, the association of leg muscle volume with
cardiovascular events was only half as strong (RR 1.31, CI,
1.05–1.63; per 1 SD lower muscle volume), and disappeared
after adjusting for additional confounders (Figure 5, Figure S5).
Sensitivity Analyses
Sensitivity analyses demonstrated that leg muscle density
was also significantly associated with major lower limb
0.5 1 2 4
RR (95% CI) per SD
Comparison Events RR (95% CI)
Leg Muscle Volume
Age & Sex 99 1.26 (0.99−1.61)
+ Vascular Risk Factors* 99 1.13 (0.87−1.47)
+ ANGIO Score 94 1.05 (0.80−1.39)
Leg Muscle Density
Age & Sex 99 1.41 (1.11−1.80)
+ Vascular Risk Factors* 99 1.31 (1.01−1.68)
+ ANGIO Score 94 1.22 (0.94−1.58)
Leg Muscle Volume
Age & Sex 97 1.31 (1.05−1.63)
+ Vascular Risk Factors* 97 1.08 (0.84−1.39)
+ ANGIO Score 93 1.11 (0.86−1.42)
Leg Muscle Density
Age & Sex 97 1.60 (1.29−1.99)
+ Vascular Risk Factors* 97 1.44 (1.14−1.83)
+ ANGIO Score 93 1.39 (1.09−1.77)
Major Lower Limb Events
Major Cardiovascular Events
95% CI
Figure 5. Association of leg muscle characteristics and major adverse events, adjusted for different risk
factors. Shown are RRs and95%CIs per SDdifference (lower) inmuscle characteristicswith different statistical
adjustments. Lower-limb event defined as any major lower-limb amputation (above- or below-knee), or
peripheral revascularization. Cardiovascular event defined as any non-fatal myocardial infarction, non-fatal
stroke, or cardiovascular death. *Additional adjustment for clinical presentation, smoking history, diabetes
mellitus, ischemic heart disease, prior stroke, and statin use. CI indicates confidence interval; SD, standard
deviation; RR, rate ratio.
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amputations after adjusting for age and sex (density: RR 1.76,
CI, 1.02–3.06, per lower SD; Figure S6). The association
between leg muscle density and cardiovascular events
remained after restricting the comparison to patients without
critical limb ischemia (intermittent claudication or atypical leg
symptoms only; Figure S7). In contrast, leg muscle density
was no longer associated with major lower limb events after
excluding people with critical limb ischemia (Figure S8). The
associations between low leg muscle density and outcome
remained after excluding the first 6 months of follow-up
(Figures S9 and S10), and when considering only non-
perioperative cardiovascular events (Figure S11).
Discussion
This study showed strong associations between low leg
muscle density and important clinical events in a high-risk
PAD population. Patients in the lowest tertile of muscle
density had 3 times the risk of lower-limb events and
cardiovascular events of those in the highest tertile of muscle
density. The association of muscle density with cardiovascular
(but not lower limb) events remained after adjusting for
cardiovascular risk factors and angiographic PAD severity,
suggesting that low leg muscle density is an independent
predictor of worse cardiovascular outcome in this population.
This is the first study to report a highly reproducible
method of assessing 3-dimensional CT leg muscle character-
istics in patients with PAD. Lower extremity muscle charac-
teristics have previously been assessed on a single slice on
cross-sectional imaging,14 which might not be representative
of the entire leg musculature. In the prospective WALCS II
(Walking and Leg Circulation Study), lower-leg muscle cross-
sectional density, but not area was associated with a
significantly higher risk of cardiovascular mortality.14 People
in the lowest tertile of cross-sectional muscle density had
triple the cardiovascular death risk of those in the highest
tertile, consistent with the present study. Interestingly, leg
muscle size was not associated with cardiovascular death in
WALCS II, but was moderately associated with cardiovascular
events in the present study after adjusting for age and sex.
This could be because of the larger number of cardiovascular
outcome events in the current study. Leg CT muscle
characteristics do not appear to be associated with cardio-
vascular events in the general population. The InChianti study
of 934 community-dwelling people found no association
between cross-sectional calf muscle density or size with
mortality after adjusting for age and sex,30 suggesting that the
prognostic value of leg muscle density may be unique to
patients with PAD.
Interestingly, low leg muscle density, but not volume, was
independently associated with risk of major cardiovascular
events. Previous studies demonstrate that decline in muscle
strength in older adults is much more rapid than concomitant
loss of muscle mass.31 This could explain why low muscle
density, but not volume, was independently associated with
risk of major cardiovascular events. Another possible expla-
nation is that low muscle density may result from myocyte fat
infiltration, which could influence cardiometabolic risk
through pro-inflammatory adipokines.32 Factors contributing
to muscle density on CT imaging are not well established.
Biopsy studies suggest that patients with PAD have a lower
proportion of type I muscle fibers, reduced capillary density,
increased muscle apoptosis, and mitochondrial
dysfunction.33–36 Moreover, the average type I muscle fiber
size and mitochondrial activity correlate strongly with 6-
minute walking distance.37 The lower muscle density in
patients with more severe PAD, as assessed from CT
angiography, likely reflects these muscle phenotype charac-
teristics of patients with PAD. Currently no research has been
performed to assess the effect of established PAD treat-
ments, such as exercise, or novel approaches, such as
mitochondrial-modifying drugs, on leg muscle phenotype in
patients with PAD, making this an important area for future
PAD research.16,38
A number of possible explanations exist for the association
between low leg muscle density and cardiovascular events. It
is possible that this association simply reflects a negative
correlation between leg muscle density and severity of
coronary and cerebrovascular atherosclerosis, as was the
case for peripheral atherosclerosis. The association of low
muscle density with cardiovascular events remained after
adjusting for established cardiovascular risk factors and the
severity of PAD, as estimated by the ANGIO Score. This
suggests that either a factor we did not adjust for, such as
physical activity, or an intrinsic effect of the leg muscle
phenotype that occurs in patients with PAD, is responsible for
this association. There is some preliminary evidence suggest-
ing that skeletal muscle itself has functional roles that may
act to reduce cardiovascular risk.39 For example, preclinical
studies demonstrate that healthy muscle secretes an array of
anti-inflammatory and cardioprotective cytokines.40,41 It is
possible, although unproven, that the observed association
may be explained in part by a reduction in cardiovascular
protective muscle cytokines.39 Further research is needed to
investigate this concept.
The rates of major clinical events in this study were high,
emphasizing the need for better management of patients with
PAD. There was imperfect uptake of effective cardiovascular
medical therapies in the population. Combined use of
effective triple medical therapy, including an antiplatelet
agent, blood pressure–lowering, and a statin, can reduce the
risk of cardiovascular events by as much as 50%.42–44
However, even with effective cardiovascular medications, the
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residual risk of major adverse events in patients with PAD is
still high. Novel interventions in addition to medications are
needed. This study tentatively suggests that interventions that
improve lower limb muscle density may reduce the risk of
cardiovascular events in PAD patients. Further research is
needed to better understand the reasons responsible for the
association between low muscle density and cardiovascular
events, and to identify and test interventions that uniquely
improve leg muscle density in PAD patients.
This study has a number of strengths and limitations. The
strengths include long-term follow-up and a highly repro-
ducible method of assessing 3-dimensional leg muscle tissue
from CT scans. The limitations include retrospective data
collection, the select PAD population recruited, and the small
sample sizes, particularly for data on ABI. Because data were
collected retrospectively, there was incomplete data on
biochemical measurements and body-mass index and rou-
tinely collected clinical data may not have been assessed
uniformly. The effect of reverse causation and unmeasured
confounders should be considered, given the retrospective
cohort design. The study included patients with PAD who were
referred to a tertiary vascular surgery clinic and who
underwent CT imaging as part of their clinical care. The
findings may not be generalizable to patients with PAD in the
community with milder symptoms. ABI measurements were
only available in a small subset of patients, so more moderate
associations between muscle characteristics and ABI may not
have been detected. Physical activity was not assessed as
part of this study, so we were not able to adjust for this in the
prognostic models. Greater physical activity has previously
been shown to be associated with increased calf muscle
density.45 Finally, there were too few major lower-limb
amputations to robustly assess the associations between CT
leg muscle characteristics and major amputation alone.
In conclusion, this study showed a strong association
between low leg muscle density and clinical events in patients
with PAD. Further research is needed to better understand the
reasons for this association.
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Supplemental Methods 
Definitions of clinical characteristics 
Clinical characteristics collected included: presenting complaint, age, sex, diabetes, 
hypertension, smoking history, ischaemic heart disease (IHD), history of stroke and 
current medications. Hypertension and diabetes were defined by history or treatment 
for these conditions. Cigarette smoking classification was based on smoking history, 
and grouped as current smoker, previous smoker or never smoked. IHD was defined 
by a history of myocardial infarction, angina or coronary revascularization. Current 
prescriptions for aspirin, other antiplatelet agents, warfarin, beta-blockers, calcium 
channel blockers, angiotensin pathway inhibitors, metformin, insulin and statins were 
recorded. 
Ankle-brachial pressure index assessment 
A 5-MHz Doppler probe (MD 6; Hokanson, Bellevue, Washington, USA) angled at 45° 
to the direction of blood flow was used to assess arterial signals in the right and left 
brachial artery, dorsalis pedis artery and posterior tibial artery. The 
sphygmomanometer cuff was inflated until the Doppler signal disappeared, and 
deflated slowly until the signal returned. The highest Doppler pressure measurement 
in each ankle (dorsalis pedis or posterior tibial) was divided by the highest brachial 
pressure to obtain an ankle-brachial pressure index (ABI) value for each foot. ABI 
comparisons were restricted to patients with compressible pedal arteries (ABI <1.4; 
toe-brachial index measurements were not performed for those with incompressible 
arteries).  
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ANGIO Score assessment 
A previously validated angiographic scoring system, named the ANGIO score, was 
applied to CT angiograms.  Scoring comprised assessment of the ten major arteries 
supplying the lower limbs. Arteries were scored 0, 1 or 2 according to the degree of 
stenosis or occlusion: 0, no stenosis or stenosis below 50 per cent; 1, non-occlusive 
stenosis of at least 50 per cent; and 2, complete occlusion of the artery. Values for all 
arteries from both lower limbs were added to produce an overall score for the patient. 
Higher scores indicate more severe lower extremity PAD. 
Reproducibility of leg muscle measurements from CT images 
All CT imaging readings were performed by two researchers (DRM and TAS). Prior to 
commencing measurements these researchers received training in CT analysis and 
performed over 10 hours of trial measurements. The reproducibility of their 
measurements was assessed by both researchers examining CT images of 30 legs 
from 15 randomly selected patients. Reproducibility was assessed on two occasions 
separated by at least one week, with blinding to previous measurements. Intra- and 
inter-observer reproducibility were assessed using concordance correlation 
coefficient, average coefficient of variation, mean difference and 95% limits of 
agreement, and Bland-Altman plots. 
Electronic data-linkage with outcome events 
Myocardial infarction and stroke were defined as events requiring hospital admission 
diagnosis, including International Statistical Classification of Diseases and Related 
Health Problems-10 (ICD-10) codes in the range I21.0-I22.9 and I60.0-I64 (inclusive), 
respectively. Mortality status, date and cause of death were obtained from the 
Queensland death register. Cardiovascular death was defined by cause of death in 
4
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the ICD-10 range I00–I99. Patients were censored at the first event, or at the date of 
last review (or linked data retrieval) if they did not experience an event.  
Sample size estimation 
A sample size calculation was performed according to the planned Cox regression 
analysis, examining the association of leg muscle characteristics with cardiovascular 
events. Monte-Carlo simulations suggest that a multivariate regression model is 
powered sufficiently when 10 outcome events per degree of freedom of the predictor 
variable are observed.1 We estimated the incidence of both primary outcome events 
to be approximately 40% over 5-years, and planned to adjust for 8 variables.2 Based 
on these estimates we considered that a sample size of approximately 200 patients 
was adequate to detect this effect size. 
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Supplemental Tables 
Table S1: Reproducibility of lower limb muscle characteristics assessed on computed tomography. 
CT Leg Muscle Characteristic CCC (95% LoA) Average CoV Mean Difference (95% LoA)
Intra-Observer Reproducibility 1 
Percent Leg Muscle Volume 0.998 (0.997-0.999) 0.29% 0.00 (-0.01 to 0.01) 
Leg Muscle Density (HU) 0.999 (0.999-1.000) 0.14% -0.04 (-0.46 to 0.37) 
Intra-Observer Reproducibility 2 
Percent Leg Muscle Volume 0.999 (0.998-1.000) 0.28% 0.00 (-0.01 to 0.00) 
Leg Muscle Density (HU) 1.000 (1.000-1.000) 0.09% 0.04 (-0.07 to 0.15) 
Inter-Observer Reproducibility* 
Percent Leg Muscle Volume 0.997 (0.995-0.999) 0.48% 0.00 (-0.01 to 0.00) 
Leg Muscle Density (HU) 1.000 (1.000-1.000) 0.12% -0.05 (-0.27 to 0.16) 
CT, computed tomography; CCC, concordance correlation coefficient; CoV, coefficient of variation; LoA, limits of agreement; HU, 
Hounsfield units. 
*Average measurements of first observer compared to average measurements of second observer.
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Table S2: Correlation of ankle-brachial pressure index with lower extremity CT 
muscle characteristics. 
CT Leg Muscle Characteristic
Correlation 
Coefficient
Standard 
Error p-value
Leg Muscle Volume (%) -0.29 0.14 0.067 
Leg Muscle Density (HU) 0.02 0.16 0.887 
Analyses conducted in 41 patients who underwent routine ankle-brachial pressure 
index assessment at the time of CT imaging, and restricted to those with 
compressible arteries (ankle-brachial pressure index <1.4). Correlation assessed 
using Spearman's method. The standard error of the correlation coefficient is 
estimated as (1-r²)/√N. CT, computed tomographic; HU, Hounsfield units. 
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Table S3: Association of ankle-brachial pressure index categories with lower extremity CT muscle characteristics. 
CT Leg Muscle Characteristic ABI ≥0.9 ABI ≥0.5, <0.9 ABI <0.5 p-value*
Leg Muscle Volume (%) 56.1 [49.5-60.2] 56.2 [49.9-58.8] 59.4 [53.9-61.2] 0.245 
Leg Muscle Density (HU) 43.8 [43.7-49.4] 45.5 [38.0-49.8] 43.1 [41.0-46.8] 0.757 
Comparison restricted to people with compressible arteries (ABI <1.4). Values are median [interquartile range]. CT, computed 
tomographic; HU, Hounsfield units; ABI, ankle-brachial pressure index. 
*Kruskal-Wallis test. 
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        Figure S1: Intra−observer differences (observer 1) for CT leg muscle volume (A) and density (B).
        The thick horizontal line represents the mean difference, and the dotted horizontal lines represent the 95% limits of agreement.
        SD, standard deviation; HU, Hounsfield units. 9
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        Figure S2: Intra−observer differences (observer 2) for CT leg muscle volume (A) and density (B).
        The thick horizontal line represents the mean difference, and the dotted horizontal lines represent the 95% limits of agreement.
        SD, standard deviation; HU, Hounsfield units. 10
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        Figure S3: Inter−observer differences for CT leg muscle volume (A) and density (B).
        The thick horizontal line represents the mean difference, and the dotted horizontal lines represent the 95% limits of agreement.
        SD, standard deviation; HU, Hounsfield units. 11
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     Figure S4: Association between leg muscle volume and major lower limb events among people with PAD.
     Left panel shows the risk of major lower limb events over time according to leg muscle volume tertile. Right panel shows the 
     relative risk of major lower limb events by leg muscle volume tertile, adjusted for age and sex. The size of the box and vertical
     lines represent the 95% confidence intervals calculated from the variance of the log risk. RR, rate ratio; CI, confidence interval.
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     Figure S5: Association between leg muscle volume and major cardiovascular events among people with PAD.
     Left panel shows the risk of major cardiovascular events over time according to leg muscle volume tertile. Right panel shows the 
     relative risk of major cardiovascular events by leg muscle volume tertile, adjusted for age and sex. The size of the box and vertical
     lines represent the 95% confidence intervals calculated from the variance of the log risk. RR, rate ratio; CI, confidence interval.
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     Figure S6: Association between leg muscle density and major lower limb amputations among people with PAD.
     Left panel shows the risk of major amputations over time according to leg muscle density tertile. Right panel shows the 
     relative risk of major amputations by leg muscle density tertile, adjusted for age and sex. The size of the box and vertical
     lines represent the 95% confidence intervals calculated from the variance of the log risk. RR, rate ratio; CI, confidence interval;
     HU, Hounsfield units. 14
D
ow
nloaded from
 http://ahajournals.org by on January 24, 2019
0 1 2 3 4 5
0
10
20
30
40
50
60
Years
M
ajo
r C
ard
io
v
as
cu
la
r E
ve
nt
s 
(%
)
Lower 1/3
Middle 1/3
Upper 1/3
l
l
l
Lower 1/3 30 24 20 18 16 11
Middle 1/3 59 52 46 40 32 26
Upper 1/3 70 64 60 55 51 43
At risk
30 35 40 45 50 55
0.5
1.0
2.0
4.0
8.0
R
R
 (9
5%
 C
I)
Leg Muscle Density (HU)
2.53
2.10
1.00
     Figure S7: Association between leg muscle density and cardiovascular events among people with IC or atypical symptoms.
     Left panel shows the risk of major cardiovascular events over time according to leg muscle density tertile. Right panel shows the 
     relative risk of major cardiovascular events by leg muscle density tertile, adjusted for age and sex. The size of the box and vertical
     lines represent the 95% confidence intervals calculated from the variance of the log risk. RR, rate ratio; CI, confidence interval;
     HU, Hounsfield units; IC, intermittent claudication. 15
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     Figure S8: Association between leg muscle density and lower limb events among people with IC or atypical symptoms.
     Left panel shows the risk of major lower limb events over time according to leg muscle density tertile. Right panel shows the 
     relative risk of major lower limb events by leg muscle density tertile, adjusted for age and sex. The size of the box and vertical
     lines represent the 95% confidence intervals calculated from the variance of the log risk. RR, rate ratio; CI, confidence interval;
     HU, Hounsfield units; IC, intermittent claudication. 16
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     Figure S9: Association between leg muscle density and lower limb events after 6 months.
     Left panel shows the risk of major lower limb events over time according to leg muscle density tertile. Right panel shows the 
     relative risk of major lower limb events by leg muscle density tertile, adjusted for age and sex. The size of the box and vertical
     lines represent the 95% confidence intervals calculated from the variance of the log risk. RR, rate ratio; CI, confidence interval;
     HU, Hounsfield units. 17
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     Figure S10: Association between leg muscle density and cardiovascular events after 6 months.
     Left panel shows the risk of major cardiovascular events over time according to leg muscle density tertile. Right panel shows the 
     relative risk of major cardiovascular events by leg muscle density tertile, adjusted for age and sex. The size of the box and vertical
     lines represent the 95% confidence intervals calculated from the variance of the log risk. RR, rate ratio; CI, confidence interval;
     HU, Hounsfield units. 18
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     Figure S11: Association between leg muscle density and non−perioperative cardiovascular events.
     Left panel shows the risk of major cardiovascular events over time according to leg muscle density tertile. Right panel shows the 
     relative risk of major cardiovascular events by leg muscle density tertile, adjusted for age and sex. Follow−up excludes time after
     any lower limb revascularisation or major amputation. The size of the box and vertical lines represent the 95% confidence intervals
     calculated from the variance of the log risk. RR, rate ratio; CI, confidence interval; HU, Hounsfield units. 19
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